Guardant Health
GH
#1787
Rank
S$14.30 B
Marketcap
S$109.02
Share price
-3.96%
Change (1 day)
80.28%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): S-$4.29

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.26. In 2024 the company made an earnings per share (EPS) of S-$4.59 an increase over its 2023 EPS that were of S-$5.51.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.29-6.49%
2024S-$4.59-16.82%
2023S-$5.51-33.13%
2022S-$8.2560%
2021S-$5.1555.04%
2020S-$3.32207.14%
2019S-$1.08-19.81%
2018S-$1.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.58-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$2.76-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA